Lipid metabolic and signalling pathways in the epidermis

Details for Australian Patent Application No. 2005270302 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. Bayer CropScience GmbH

Inventors Trenkamp, Sandra; Saedler, Heinz; Schreiber, Lukas; Tietjen, KlausGunther; Yephremov, Alexander

Agent Griffith Hack

Pub. Number AU-A-2005270302

PCT Pub. Number WO2006/015848

Priority 04018824.5 09.08.04 EP

Filing date 9 August 2005

Wipo publication date 16 February 2006

International Classifications

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

A01H 5/00 (2006.01) Products

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015848 Priority application(s): WO2006/015848

13 December 2007 Alteration of Name

  The name of the applicant has been altered to Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.; Bayer CropScience AG

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270305-Piperazine derivatives with CCR3 inhibiting activity

2005270230-Prostaglandin analogs